Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.
Read Full NewsIn this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on RBD as a prodromal marker for synucleinopathies!
Psoriatic Arthritis in 2025: Year in Review
Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval
1.
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk
2.
Prostate cancer detection with PET CT and PET MRI is comparable.
3.
COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?
4.
Novel Agent Effective for Cancer Wasting Disorder
5.
A new way to measure suicide risk?
1.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
2.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
3.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
4.
Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer
5.
Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
3.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge